Your session is about to expire
← Back to Search
STAIR Therapy for Post-Traumatic Stress Disorder and Emotion Regulation
N/A
Waitlist Available
Led By Sanno Zack, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have a DSM-5 diagnosis and/or symptoms for which DBT is an indicated treatment
Be 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1 through week 12
Awards & highlights
Study Summary
This trial will study whether a new therapy, STAIR, is effective in treating PTSD, emotional dysregulation, and borderline personality disorder symptoms.
Who is the study for?
This trial is for adults with PTSD or Borderline Personality Disorder symptoms, who can commit to group therapy rules. It's not suitable for those already in DBT or trauma-focused therapy.Check my eligibility
What is being tested?
The study tests the STAIR group therapy's effectiveness on PTSD and emotional dysregulation compared to standard treatments like DBT, aiming to improve mental health care quality.See study design
What are the potential side effects?
STAIR is a psychological intervention; side effects may include temporary increases in distress as difficult emotions and experiences are processed during treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a mental health condition that can be treated with DBT.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 1 through week 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1 through week 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Borderline Symptom List-23 total score from baseline to Week 12
Change in Borderline symptom severity total score from baseline to Week 12
Change in current symptoms of psychopathology and psychological distress total score from baseline to Week 12
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Waitlist controlExperimental Treatment1 Intervention
First, participants will remain on the DBT waitlist for 12 weeks receiving no active intervention and will complete pre and post-measures. Then participants will complete 1.5 hr group sessions once per week for 12 weeks of Skills Training in Affective and Interpersonal Regulation (STAIR). Participants will complete self-report measures pre, post, and at one month intervals.
Group II: STAIRExperimental Treatment1 Intervention
Participants will complete 1.5 hr group sessions once per week for 12 weeks of Skills Training in Affective and Interpersonal Regulation (STAIR). Participants will complete self-report measures pre, post, and at one month intervals.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STAIR
2011
N/A
~70
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,387 Previous Clinical Trials
17,334,020 Total Patients Enrolled
4 Trials studying Emotion Regulation
527 Patients Enrolled for Emotion Regulation
Sanno Zack, PhDPrincipal InvestigatorStanford Universtiy
Emily Livermore, PsyDPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a mental health condition that can be treated with DBT.I am 18 years old or older.I show at least three symptoms of borderline personality disorder.I am currently undergoing a specific therapy for trauma.My doctor advised against STAIR therapy for me.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: STAIR
- Group 2: Waitlist control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Emotion Regulation Patient Testimony for trial: Trial Name: NCT05397613 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open enrollments for this research study?
"As indicated on the clinicaltrials.gov website, this medical trial is no longer actively recruiting individuals for participation. The study was initiated on June 15th 2022 yet ceased taking participants following a May 25th edit. Despite its inactivity, there are still 1288 other trials accepting sign-ups at present."
Answered by AI
Who else is applying?
What state do they live in?
California
Texas
Ohio
How old are they?
18 - 65
What site did they apply to?
Stanford University
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
1
2
3+
0
Why did patients apply to this trial?
I'm desperate for help I don't know what else to do. For furthering BPD knowledge and helping find effective specialized treatments for myself and others with my diagnosis BPD.
PatientReceived no prior treatments
I am stuck. I want to change my behaviors , emotional dysregulation and treat my ptsd also. I am willing to try anything at this point.
PatientReceived 1 prior treatment
I’m currently getting more insight on this condition and wanting to learn more about What treatment is being tested for this study? is there also a neurologist who will do a brain scan to see the frontal cortex damage and other speculations they may see on me?
PatientReceived no prior treatments
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger